首页|复方苦参注射液联合阿片类镇痛药对结直肠癌晚期患者疼痛、生活质量及凝血功能的改善效果观察

复方苦参注射液联合阿片类镇痛药对结直肠癌晚期患者疼痛、生活质量及凝血功能的改善效果观察

扫码查看
目的:探讨复方苦参注射液联合阿片类镇痛药对结直肠癌(CRC)晚期患者疼痛、生活质量及凝血功能的改善效果,并查阅文献初步探讨相关作用机制。方法:选取2019年1月至2024年3月该院收治的CRC晚期患者106例,根据随机数字表法分为单药组(n=53,给予盐酸曲马多或盐酸羟考酮治疗)、联合用药组(n=53,给予复方苦参注射液联合盐酸曲马多或盐酸羟考酮治疗)。比较两组患者治疗前后的视觉模拟评分(VAS)和疼痛缓解程度、生活质量[卡诺夫斯凯计分(KPS)]及凝血功能状况(D-二聚体和纤维蛋白原表达水平)。结果:治疗前,两组患者VAS评分、KPS评分、D-二聚体和纤维蛋白原表达水平的差异均无统计学意义(P>0。05)。治疗后,联合用药组患者的VAS评分为(1。28±1。08)分,明显低于单药组的(2。72±0。72)分;联合用药组患者的疼痛缓解程度显著优于单药组,差异均有统计学意义(P<0。05)。治疗后,联合用药组患者的KPS评分为(85。28±11。23)分,高于单药组的(78。87±12。81)分,差异有统计学意义(P<0。05)。治疗后,单药组患者凝血功能指标(D-二聚体和纤维蛋白原)表达水平较治疗前轻度升高,但差异无统计学意义(P>0。05);联合用药组患者凝血功能指标表达水平较治疗前显著降低,且低于同期对照组,差异均有统计学意义(P<0。05)。结论:复方苦参注射液联合盐酸阿片类镇痛药用于CRC晚期患者,在缓解疼痛、提升生活质量及改善凝血功能方面的治疗效果满意。
Improvement Effects of Compound Kushen Injection Combined with Opioid Analgesics on Pain,Quality of Life,and Coagulation Function in Patients with Advanced Colorectal Cancer
OBJECTIVE:To probe into the improvement effects of compound Kushen injection combined with opioid analgesics on pain,quality of life,and coagulation function in patients with advanced colorectal cancer(CRC),and to explore the relevant mechanism of action by reviewing literature.METHODS:Totally 106 patients with advanced CRC admitted into the hospital from Jan.2019 to Mar.2024 were extracted to be divided into the monotherapy group(n=53,treated with tramadol hydrochloride or oxycodone hydrochloride)and combination therapy group(n=53,treated with compound Kushen injection combined with tramadol hydrochloride or oxycodone hydrochloride)via the random number table method.Visual Analogue Scale(VAS)scores,pain relief,quality of life(KPS score)and coagulation function(D-dimer and fibrinogen expression levels)were compared between two groups before and after treatment.RESULTS:Before treatment,there was no significant difference in VAS score,KPS score,D-dimer and fibrinogen expression levels between two groups(P>0.05).After treatment,the VAS score in the monotherapy group was(1.28±1.08)points,lower than(2.72±0.72)points in the combination therapy group;the degree of pain relief in the combination therapy group was significantly better than that in the monotherapy group,with statistically significant difference(P<0.05).After treatment,the KPS score of combination therapy group was(85.28±11.23)points,higher than(78.87±12.81)points of monotherapy group,the difference was statistically significant(P<0.05).After treatment,the expression levels of coagulation function indicators(D-dimer and fibrinogen)in monotherapy group were slightly higher than those before treatment,the difference was not statistically significant(P>0.05);the expression levels of coagulation function indicators of patients in the combination group was significantly lower than those before treatment,and lower than thos of the control group in the same period,the differences were statistically significant(P<0.05).CONCLUSIONS:The combination of compound Kushen injection and opioid analgesics is effective in relieving pain,improving quality of life and coagulation function in patients with advanced CRC.

Compound Kushen injectionOpioid analgesicsColon cancerQuality of lifePainCoagulation function

王春花、祝永福

展开 >

安徽中医药大学第一附属医院肿瘤科,合肥 230000

复方苦参注射液 阿片类镇痛药 结直肠癌 生活质量 疼痛 凝血功能

2022年安徽省高等学校科学研究项目

2022AH050415

2024

中国医院用药评价与分析
中国医药生物技术协会,中国药房杂志社

中国医院用药评价与分析

CSTPCD
影响因子:1.142
ISSN:1672-2124
年,卷(期):2024.24(8)